Take a Breath: Selecting a Device for Inhaled Product Development

This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme.

The future commercial success of any new inhaled medicine relies largely on the correct combination of formulation and device technology chosen for its delivery. This presentation benefits any drug developer considering an inhaled programme and aims to answer the following questions:

How are development targets and success criteria set for inhaled products?

What are the key factors influencing inhaled delivery platform selection?

How can phase-appropriate device selection accelerate an inhaled development programme?